Compliance Rate

Compliance Rate 51.23%
Compliant submissions 187
Incompliant submissions 178
Total trials 365

My Organizations' Clinical Trials

Showing 2225 of 2400 entries
View as:

Evaluating the Safety and Pharmacokinetics of PC-1005 Administered Rectally to HIV-1 Seronegative Adults

Phase: N/A Priority: Normal
NCT ID: NCT03408899 Org: User:
Start: 06/19/18 End: 04/19/19 Due: 04/19/20

Pharmacodynamics of Intermittent IL-2 Infusions in HIV Seropositive Patients

Phase: N/A Priority: Normal
NCT ID: NCT00001474 Org: User:
Start: 05/31/95 End: 03/31/02 Due: 03/31/03

Trivalent rHA Dose Escalation Study in Elderly Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00170443 Org: User:
Start: - End: 06/30/04 Due: 06/30/05

A Study to See If Taking One or Two Extra Drugs Can Lower HIV Levels in Patients Who Have Failed Their Anti-HIV Drug Treatment

Phase: N/A Priority: Normal
NCT ID: NCT00006152 Org: User:
Start: - End: 08/31/02 Due: 08/31/03

ADRN Barrier/Immunoprofiling Exploratory Pilot Study

Phase: N/A Priority: Normal
NCT ID: NCT02115399 Org: User:
Start: 04/30/14 End: 06/30/15 Due: 06/30/16

Safety and Immune Response to a Prime-Boost Vaccination Schedule in HIV-infected Patients

Phase: N/A Priority: Normal
NCT ID: NCT00270465 Org: User:
Start: 12/21/05 End: 06/25/09 Due: 06/25/10

A Comparison of Three Treatments for Advanced HIV Disease in Patients Who Have Received Nucleoside Therapy in the Past

Phase: N/A Priority: Normal
NCT ID: NCT00001029 Org: User:
Start: - End: 05/31/93 Due: 05/31/94

Evaluating the Pharmacokinetics of High-Dose Rifapentine When Given as a Single Dose or in Divided Doses to Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT01574638 Org: User:
Start: 06/30/12 End: 06/30/13 Due: 06/30/14

B-Lymphocyte Immunotherapy in Islet Transplantation

Phase: N/A Priority: Normal
NCT ID: NCT00468442 Org: User:
Start: 11/30/06 End: 09/30/11 Due: 09/30/12

Study of Semaglutide for Non-Alcoholic Fatty Liver Disease (NAFLD), a Metabolic Syndrome With Insulin Resistance, Increased Hepatic Lipids, and Increased Cardiovascular Disease Risk (The SLIM LIVER Study)

Phase: N/A Priority: Normal
NCT ID: NCT04216589 Org: User:
Start: 02/19/21 End: 09/15/23 Due: 09/15/24

H7N9 Mix and Match With MF59 in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT01938742 Org: User:
Start: 09/30/13 End: 11/30/14 Due: 11/30/15

Dyskinesia, Heterotaxy and Congenital Heart Disease

Phase: N/A Priority: Normal
NCT ID: NCT00608556 Org: User:
Start: 01/25/08 End: 10/31/11 Due: 10/31/12

T Cell Cytokine Changes During IL-4 Receptor Treatment for Asthma

Phase: N/A Priority: Normal
NCT ID: NCT00001908 Org: User:
Start: 06/30/99 End: 07/31/01 Due: 07/31/02

Safety Study of a Human Metapneumovirus Challenge Virus in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT01109329 Org: User:
Start: 06/30/10 End: 12/31/10 Due: 12/31/11

Safety Study of Intravenous Ertapenem in Combination With Zidebactam (WCK 6777)

Phase: N/A Priority: Normal
NCT ID: NCT05645757 Org: User:
Start: 04/19/23 End: 11/03/23 Due: 11/03/24

CROSSOVER STUDY OF ON-DEMAND PREP FORMULATIONS COMPARING RECTAL AND ORAL TENOFOVIR

Phase: N/A Priority: Normal
NCT ID: NCT06560684 Org: User:
Start: 10/29/24 End: 01/31/26 Due: 01/31/27

Trial of Novel Regimens for the Treatment of Pulmonary Tuberculosis

Phase: N/A Priority: Normal
NCT ID: NCT06192160 Org: User:
Start: 03/11/25 End: 03/11/27 Due: 03/11/28

Recombinant Human IL-4 Receptor Used in Treatment of Asthma

Phase: N/A Priority: Normal
NCT ID: NCT00017693 Org: User:
Start: 05/31/98 End: 02/29/00 Due: 02/28/01

A Phase I, Randomized, Double-Blind, Placebo-Controlled, Clinical Trial to Compare the Safety and Immunogenicity of Recombinant Envelope Protein rgp120/HIV-1SF2 (BIOCINE) Combined With Seven Adjuvants in Healthy HIV-1 Uninfected Individuals

Phase: N/A Priority: Normal
NCT ID: NCT00001042 Org: User:
Start: - End: 03/31/96 Due: 03/31/97

A Study to Evaluate the Safety, Tolerability and Plasma PK of a Single Oral Dose of Zoliflodacin in Healthy Male and Female Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT03404167 Org: User:
Start: 02/02/18 End: 03/02/18 Due: 03/02/19

11C-5-HTP PET in Clinical Islet Transplantation

Phase: N/A Priority: Normal
NCT ID: NCT02689479 Org: User:
Start: 05/31/13 End: 09/30/14 Due: 09/30/15

The Safety and Effectiveness of Adefovir Dipivoxil in the Treatment of HIV-Infected Patients

Phase: N/A Priority: Normal
NCT ID: NCT00001082 Org: User:
Start: 12/31/96 End: 08/31/99 Due: 08/31/00

Tocilizumab in Cardiac Transplantation

Phase: N/A Priority: Normal
NCT ID: NCT03644667 Org: User:
Start: 12/20/18 End: 03/21/25 Due: 03/21/26

Fluorodeoxyglucose-Positron Emission Tomography (FDG-PET) to Evaluate Autoimmune Lymphoproliferative Syndrome (ALPS) and ALPS-associated Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00068146 Org: User:
Start: 09/19/02 End: 11/26/12 Due: 11/26/13

Once-Daily Drug Regimen for HIV-Infected Patients

Phase: N/A Priority: Normal
NCT ID: NCT00001968 Org: User:
Start: 01/31/00 End: 11/30/00 Due: 11/30/01